The aim of this review is to synthesize recent evidence on the relationship between GDF-15 and different subclinical atherosclerosis markers, and to evaluate whether GDF-15 may represent an integrative biomarker reflecting shared pathways between atherosclerosis, obesity, and heart failure. Here, GDF15 is linked to obesity due to melanocortin 4 receptor deficiency.